Stay updated on Anti-OX40 Antibody in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Anti-OX40 Antibody in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Anti-OX40 Antibody in Atopic Dermatitis Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A consolidated Locations section is added listing study sites in California, Colorado, Florida, Massachusetts, New York, North Carolina, Ohio, Oregon, Texas, Ontario, and Quebec. Previous per-location pages were removed and the study record revision updated to v3.3.3.
    Difference
    0.8%
    Check dated 2025-12-23T22:05:52.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    The Publications section now states that publications are automatically filled from PubMed and may not be about the study, and the Revision line has changed from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T11:29:14.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Removed the government funding operating-status notice from the page; the content now presents only the study details without that disclaimer.
    Difference
    0.2%
    Check dated 2025-11-18T07:14:17.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    There are no significant changes to core study information between screenshots; the page content remains the same and any differences are limited to minor formatting or collapsed sections. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T21:18:32.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Update includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. The core effect is informing users about possible delays and the current open status of the NIH Clinical Center.
    Difference
    2%
    Check dated 2025-10-06T05:34:40.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Major change: page now shows Revision: v3.1.0 and removes several drug-safety topics; indicates a content reorganization with updated versioning rather than new substantive information in the deleted areas.
    Difference
    0.2%
    Check dated 2025-09-29T03:06:22.000Z thumbnail image

Stay in the know with updates to Anti-OX40 Antibody in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Anti-OX40 Antibody in Atopic Dermatitis Clinical Trial page.